Buscar
Mostrando ítems 1-10 de 13
Trombolisis endovenosa post reversión de acenocumarol con complejo de protrombina. Caso clínico
(Sociedad Médica de Santiago, 2019)
We report an 89-year-old male under oral anticoagulant therapy with a therapeutic international normalized ratio, presenting at the emergency room with right side hemiparesis and aphasia. Neuroimaging was compatible with ...
Trombolisis endovenosa con tenecteplase en ventana extendida tras selección por CT y AngioCT: Caso clínico
(2021)
We report a 78-year-old man with a basal Rankin score of 2 points, last seen
10 hours before in good conditions, who arrived at the emergency department
with left hemiparesis, hypoesthesia, and spacial neglect. Neuroimaging ...
Experiencia de trombolisis sistematizada en infarto cerebral agudo en un hospital público de Chile
(2011)
Background: The only accepted treatment for acute ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (t-PA). It was implemented in Chile in 1996, although its use was mainly restricted in Chile ...
Determinantes del tiempo puerta-aguja en trombolisis endovenosa en el infarto cerebral, experiencia de un centro
(2020)
Background: Intravenous thrombolysis (IT) in acute ischemic stroke (AIS)
is time dependent. The time elapsed from hospital admission to the thrombolytic
bolus is named door to needle time (DNT) and is recommend to be of ...
Telestroke in Chile: 1 year experience at 7 hospitals
(2019)
Background: Acute ischemic stroke (AIS) is one of the leading causes of death in Chile. Intravenous thrombolysis (IVT) is an effective treatment. Geographical barriers and lack of specialists limit its application. ...
Stroke Care and Application of Thrombolysis in Ibero-America: Report From the SITS-SIECV Ibero-American Stroke Register
(2019)
Background and Purpose—
Standardized registries may provide valuable data to further improve stroke care. Our aim was to obtain updated information about characteristics of stroke patients and management of stroke across ...
Exclusion Criteria for Intravenous Thrombolysis in Stroke Mimics: An Observational Study
(2013)
Background: Stroke mimics (SMs) are frequent in emergency departments (EDs), but are treated infrequently with intravenous recombinant tissue plasminogen activator (rt-PA) thrombolysis. We aimed at identifying the factors ...
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
(Elsevier Ltd., 2019-03)
Background
Systolic blood pressure of more than 185 mm Hg is a contraindication to thrombolytic treatment with intravenous alteplase in patients with acute ischaemic stroke, but the target systolic blood pressure for ...
In-Hospital Acute Ischemic Stroke is Associated with Worse Outcome: Experience of a Single Center in Santiago Chile
(2021)
Objectives: In-hospital acute ischemic stroke (HIS) accounts for 217% of all acute ischemic strokes (AIS) seen in hospital and they have worse prognosis. In this study we aimed to identify the frequency of HIS and their ...